Literature DB >> 11200690

Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis.

M Rovaris1, M Inglese, R A van Schijndel, M P Sormani, M Rodegher, G Comi, M Filippi.   

Abstract

The course of multiple sclerosis (MS) can be monitored by measuring changes in brain volume, but consensus is still lacking on the best strategy to be adopted. We compared the reproducibility and sensitivity of volume measurements from different brain portions for detecting changes on magnetic resonance imaging (MRI) in patients with MS. T1-weighted MRI of the brain was performed in 50 patients with relapsing-remitting MS at study entry and after an average follow-up of 18.4 months. Using a semiautomated technique for brain parenchyma segmentation, the volumes of the following brain portions were measured: (a) the whole brain (whole-brain volume, WBV), (b) the seven slices rostral to the velum interpositum (seven-slice volume, SSV), (c) the central slice of the image set (central-slice volume, CSV) and (d) the infratentorial regions (infratentorial-brain volume, IBV). All these measurements were carried out by a single observer and were repeated twice on ten randomly selected scans to test the intra-observer reproducibility using the four strategies. At follow-up there was a significant decrease in all the measures of brain volume (P ranged from 0.002 to < 0.001). The univariate correlations between changes in WBV, SSV, CSV and IBV were all statistically significant, with the exception of that between changes in CSV and IBV; r values ranged from 0.34 (for the WBV/IBV correlation) to 0.80 (for the WBV/SSV correlation). The mean intra-observer coefficient of variations were 1.9% for WBV, 1.5% for SSV, 2.9% for CSV and 2.2% for IBV measurements. The measurement of volume on a portion of brain selectively including the regions in which MS pathology is more diffuse is as reliable and sensitive to disease-related changes as that on the whole brain, with significant time saving for processing.

Entities:  

Mesh:

Year:  2000        PMID: 11200690     DOI: 10.1007/s004150070054

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype.

Authors:  Elisabetta Pagani; Maria A Rocca; Antonio Gallo; Marco Rovaris; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

2.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.

Authors:  M Bozzali; A Falini; M Franceschi; M Cercignani; M Zuffi; G Scotti; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

3.  Standardized, reproducible, high resolution global measurements of T1 relaxation metrics in cases of multiple sclerosis.

Authors:  Radhika Srinivasan; Roland Henry; Daniel Pelletier; Sarah Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

4.  Infratentorial lesion volume correlates with sensory functional system in multiple sclerosis patients: a 3.0-Tesla MRI study.

Authors:  C C Quattrocchi; A Cherubini; G Luccichenti; M G Grasso; U Nocentini; B Beomonte Zobel; U Sabatini
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

5.  Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study.

Authors:  Sarlota Mesaros; Maria A Rocca; Maria P Sormani; Arnaud Charil; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol       Date:  2008-07-03       Impact factor: 4.849

Review 6.  Interventions for the prevention of brain atrophy in multiple sclerosis : current status.

Authors:  Marco Rovaris; Massimo Filippi
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging.

Authors:  Marco Bozzali; Mara Cercignani; Maria Pia Sormani; Giancarlo Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

8.  The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Ioannis Heliopoulos; Panagiotis Papathanasopoulos; Efthimios Dardiotis; Constantinos Kilidireas; Konstantinos Voumvourakis
Journal:  Ther Adv Neurol Disord       Date:  2015-09       Impact factor: 6.570

Review 9.  Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.

Authors:  David H Miller
Journal:  NeuroRx       Date:  2004-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.